Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03726489 · ClinicalTrials.gov registry record · NA
Light Treatment Effectiveness (LITE) Study
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 783
- Enrollment target
NCT03726489: Completed NA study, sponsored by University of Pennsylvania.
NCT03726489 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 783 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03726489, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 783 participants
- Enrollment target
Study Summary
To compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based narrowband ultraviolet B phototherapy for the treatment of psoriasis
Primary Outcome
Measure of clinical treatment response, with PGA score of 0/1 (clear/almost clear). PGA score range from 0 (clear) to 5 (worst disease state).
Interventions
- DEVICE Daavlin 7 series 3 panel narrow band phototherapy home units
- DEVICE narrow band phototherapy clinic units
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 783 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2023-12-30 |
| Phase | NA |
What the finished NCT03726489 record still lists
NCT03726489 is an interventional study that assigns participants to a tested intervention. The registered 783 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower).
The record links to 0 conditions, and to 2 interventions - of which Daavlin 7 series 3 panel narrow band phototherapy home units is the first listed.
NCT03726489 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03726489 about?
NCT03726489 is a clinical study titled "Light Treatment Effectiveness (LITE) Study". To compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based narrowband ultraviolet B phototherapy for the treatment of psoriasis
What is the current status of trial NCT03726489?
This trial is currently completed. It is a NA study. The enrollment target is 783 participants. The study started on 2019-03-01. Estimated completion is 2023-12-30.
What interventions are being tested in trial NCT03726489?
The interventions under investigation include: Daavlin 7 series 3 panel narrow band phototherapy home units (DEVICE), narrow band phototherapy clinic units (DEVICE).
Who is sponsoring clinical trial NCT03726489?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03726489's enrollment target sits among peer trials
783 141st of 2000 higher than 1,860 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06575192 · 783 participants · Phase 3
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
- NCT06118723 · 784 participants
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- NCT06498128 · 785 participants
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
- NCT07276724 · 786 participants · Phase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI